EDGE THERAPEUTICS, INC 10-Q 6-30-2016

Company

PDS Biotechnology Corp

Filed

August 3, 2016

Period of Report

June 30, 2016

Accession Number

0001140361-16-074623

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →